AstraZeneca PLC

AZN

GB0009895292

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:08 2024-04-25 am EDT			5-day change	1st Jan Change
12,026 ^GBX	+5.94%		+10.19%	+13.45%

07:58pm	Sector Update: Health Care Stocks Drop in Afternoon Trading	MT
06:54pm	Top Midday Stories: Shares of Meta, IBM, Caterpillar, Comcast and Southwest Down Big Post-Earnings; AstraZeneca Shares See Post-Earnings Bump	MT

ASTRAZENECA : Gets a Buy rating from Barclays

February 15, 2022 at 05:19 am EST

In a research note, Barclays analyst Emily Field has maintained his recommendation on the stock with a Buy rating. The target price remains unchanged at GBX 11500.

Latest news about AstraZeneca PLC

Sector Update: Health Care Stocks Drop in Afternoon Trading	01:58pm	MT
Top Midday Stories: Shares of Meta, IBM, Caterpillar, Comcast and Southwest Down Big Post-Earnings; AstraZeneca Shares See Post-Earnings Bump	12:54pm	MT
ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade	12:02pm
FTSE 100 shakes off red-hot US inflation gauge	11:58am	AN
Global markets live: Ford, Dow, American Airlines, Comcast, Apple, IBM, Cisco...	11:43am
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	11:11am	MT
ASTRAZENECA : UBS maintains a Sell rating	09:40am	ZD
Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday	09:22am	MT
The specter of stagflation rears its ugly head again	09:21am
Dpa-AFX Overview: COMPANIES from 25.04.2024 - 15:15	09:20am	DP
Sector Update: Health Care	08:55am	MT
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Thursday Ahead of Key Economic Data	08:33am	MT
ASTRAZENECA : Jefferies sticks Neutral	08:25am	ZD
ASTRAZENECA : JP Morgan remains its Buy rating	08:15am	ZD
FTSE 100 hits high on offer for Anglo American	06:52am	AN
Transcript : AstraZeneca PLC, Q1 2024 Earnings Call, Apr 25, 2024	06:45am
AstraZeneca Q1 Core Earnings, Revenue Increase -- Shares Jump Premarket	06:31am	MT
ANALYST RECOMMENDATIONS : Meta Platforms, UPS, Boeing, Chipotle, Dell Technologies...	05:58am
AstraZeneca Earnings, Sales Rise, Beating Forecasts -- Update	05:43am	DJ
European Midday Briefing : Mood Cautious Ahead of More U.S Tech, Key Data	05:20am	DJ
London rises ahead of US GDP data	04:56am
AstraZeneca: strong sales growth in Q1	04:34am	CF
AstraZeneca upbeat as cancer drugs underpin sales growth	04:20am	AN
Anglo American jumps on takeover bid from BHP	04:14am	AN
FTSE 100 hits record high on big mining M&A, earnings push	03:24am	RE

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Sector

Pharmaceuticals

Calendar

02:00am - Q1 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR) , FTSE 100

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

ASTRAZENECA : Strong Q1 raises hopes of a guidance upgrade

April 25, 2024 at 12:02 pm EDT

More Strategies

Ratings for AstraZeneca PLC

Trading Rating

Investor Rating

ESG Refinitiv

B+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

141.1 USD

Average target price

161.4 USD

Spread / Average Target

+14.36%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
ASTRAZENECA PLC	+13.45%	219B
NOVO NORDISK A/S	+24.17%	562B
JOHNSON & JOHNSON	-6.27%	358B
MERCK & CO., INC.	+19.22%	322B
ABBVIE INC.	+7.71%	297B
NOVARTIS AG	+6.04%	199B
ROCHE HOLDING AG	-10.51%	196B
PFIZER, INC.	-11.72%	149B
AMGEN INC.	-6.31%	146B
SANOFI	+2.07%	117B

Other Pharmaceuticals

AstraZeneca PLC

Equities

AZN

GB0009895292

Pharmaceuticals

ASTRAZENECA : Gets a Buy rating from Barclays

Latest news about AstraZeneca PLC

Chart AstraZeneca PLC

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for AstraZeneca PLC

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals